Biora Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOR research report →
About the company
Biora Therapeutics, Inc. is a biotechnology company focused on developing cutting-edge oral biotherapeutic solutions. The company's core efforts involve two main therapeutic programs: Targeted Therapeutics: This program utilizes an advanced ingestible smart capsule designed to deliver medications precisely within the gastrointestinal (GI) tract.
- CEO
- Aditya Mohanty
- IPO
- 2020
- Employees
- 58
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $994.99K
- P/E
- -0.00
- P/S
- 3.39
- P/B
- -0.00
- EV/EBITDA
- -0.28
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -1678575.00%
- Net Margin
- -3102875.00%
- ROE
- 121.86%
- ROIC
- 232.28%
- Revenue
- $4.00K · -98.69%
- Net Income
- $-124,115,000 · -225.27%
- EPS
- $-78.70 · -1129.69%
- Op Income
- $-67,143,000
- FCF YoY
- 25.47%
- 52W High
- $0.38
- 52W Low
- $0.15
- 50D MA
- $0.22
- 200D MA
- $0.22
- Beta
- 1.28
- Avg Volume
- 60.81K
Get TickerSpark's AI analysis on BIOR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BIOR coverage
Recent articles, reports, and earnings notes.
No research on BIOR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIOR report →Similar companies
Peers in the same neighborhood.